64Cu diacetyl-bis (N4- methylthiosemicarbazone) (LinqMed/PDRadiopharma)

N/A

Report date: 2025/11/21 17:16:29
NME

Base Information

Drug Name64Cu diacetyl-bis (N4- methylthiosemicarbazone) (LinqMed/PDRadiopharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionDNA damage stimulants
TargetsDNA
Therapy Area/IndicationsBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLinqMed Inc
China Registration ClassN/A

Develop Information

Active CompaniesPDRadiopharma IncLinqMed Inc
Inactive CompaniesN/A
Active IndicationsBrain Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A